Oral fumarate for relapsing-remitting multiple sclerosis

Lancet. 2008 Oct 25;372(9648):1447-8. doi: 10.1016/S0140-6736(08)61605-0.
No abstract available

Publication types

  • Comment
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Dimethyl Fumarate
  • Dose-Response Relationship, Drug
  • Fumarates / administration & dosage
  • Fumarates / adverse effects
  • Fumarates / therapeutic use*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Fumarates
  • Immunosuppressive Agents
  • Dimethyl Fumarate